3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
55
Multiple Myeloma
53
Hodgkin Disease
51
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Lymphoma, Non-Hodgkin
46
Leukemia, Lymphocytic, Chronic, B-Cell
44
Myelodysplastic Syndromes
41
Lymphoma, Mantle-Cell
39
Lymphoma, Large B-Cell, Diffuse
38
Lymphoma, Follicular
36
Leukemia
36
Congenital Abnormalities
36
Burkitt Lymphoma
34
Myeloproliferative Disorders
31
Lymphoma
30
Lymphoma, B-Cell, Marginal Zone
29
Lymphoma, Large-Cell, Immunoblastic
28
Leukemia, Myeloid, Accelerated Phase
27
Leukemia, Myeloid, Chronic-Phase
26
Waldenstrom Macroglobulinemia
25
Blast Crisis
25
Leukemia, Myelomonocytic, Chronic
24
Recurrence
19
Primary Myelofibrosis
19
Lymphoma, T-Cell, Cutaneous
19
Neoplasms, Plasma Cell
18
Lymphoma, Large-Cell, Anaplastic
18
Myelodysplastic-Myeloproliferative Diseases
16
Sezary Syndrome
15
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Interventions
HhAntag691
2
toripalimab
1
temsirolimus
1
pegfilgrastim
1
pazopanib
1
liposomal doxorubicin
1
enasidenib
1
angiotensin I (1-7)
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Proton Therapy
1
Pharmacogenomic Testing
1
Microarray Analysis
1
Medicare Part B
1
Magnetic Resonance Spectroscopy
1
Immunologic Techniques
1
Gemcitabine
1
Filgrastim
1
Ferrosoferric Oxide
1
Fentanyl
1
Docetaxel
1
Dasatinib
1
Cyproheptadine
1
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chondrosarcoma
×
Peripheral Blood Stem Cell Transplantation
×
Clear all
No trials found.